Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B round of financing that will be used to expand the company’s DNA synthesis production capacity in the U.S. The San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback